According to Bloomberg News, “Airbus Group NV (AIR)’s A350 jet landed at the company’s Toulouse base in southern France last night to end 14 months of trials that pave the way for the new model’s certification and first delivery later this year.”
Tesla has resolved a longstanding trade issue over its company branding in China that involved its namesake.
According to CNET, “Benzene and n-hexane are chemicals thought to cause cancer and nerve damage, and they both have been used in the final assembly of Apple’s iPhones, iPads, iPods, and Mac computers — until now.”
According to NASDAQ, “CEO Mary Barra said General Motors will invest $2.8 billion in Brazil over the next five years. Speaking to reporters in Brasilia after meeting President Dilma Rousseff, Barra said the new investment will [be] spent on new products, technology and maintaining plants. She said there were some mid-term challenges ahead, but that…
September can’t come soon enough for NASA engineers who will unveil a state-of-the-art 3D-printed imagining telescope that will serve as a space camera. Currently, the project is being led by engineer Jason Budinoff.
According to the Associated Press wire, “The U.S. economy already has been showing renewed strength. Economic growth clocked in an impressive 4 percent annual pace from April through June after getting off to a bad start the first three months of the year. And the Labor Department said Friday that employers added more than 200,000…
According to Market Watch, “The country’s economy ministry said orders fell 3.2 percent in adjusted terms in June from May, compared with a 1.6 percent decline in May from April. Analysts polled by The Wall Street Journal had forecast a rise of 0.8 percent.”
According to The Wall Street Journal, “A Chinese auto-parts factory where at least [75] workers were killed in a weekend explosion was known for high levels of dust and excess overtime, according to current and former workers, who described intense pressure to supply parts for a fast-growing industry.”
The ongoing Ebola epidemic in West Africa has brought on a global call for action. The message is being sent directly to pharma manufacturers. The issue remains: Currently, there is no medicine or vaccine that’s registered, let alone approved, to treat the deadly disease.
According to the Wall Street Journal, “Coca-Cola Co. said it plans to spend more than $5 billion in Africa over the next six years, lifting the U.S. beverage giant’s proposed investments in Africa to $17 billion for 2010 to 2020. The Atlanta-based company also signed a preliminary agreement to launch an initiative — called Source…